Related Experiment Video
Updated: May 13, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Metastamir-mediated immune evasion: miR-10b downregulates the stress-induced molecule MICB, hence avoid recognition
Pinchas Tsukerman1, Jonatan Enk, Ofer Mandelboim
1Lautenberg Center for General and Tumor Immunology; The Hebrew University; The BioMedical Research Institute; Hadassah Medical School; Jerusalem, Israel.
Abstract:
Metastases are responsible for more than 90% of cancer-related deaths. We have recently reported that miR-10b inhibits the expression of MICB, a stress-induced ligand of the activating natural killer (NK)-cell receptor NKG2D. Here, we discuss our findings, which link metastasis formation to immune evasion.
Insights
MicroRNA-10b (miR-10b) promotes cancer metastasis by inhibiting MICB, a molecule that activates natural killer (NK) cells. This mechanism helps tumors evade immune detection, contributing to cancer mortality.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Metastasis is the primary cause of cancer-related mortality, accounting for over 90% of deaths.
- Immune evasion is a critical hallmark of cancer, enabling tumor cells to survive and spread.
- MICB, a ligand for the NKG2D receptor, plays a role in natural killer (NK) cell-mediated anti-tumor immunity.
Purpose of the Study:
- To investigate the role of miR-10b in regulating MICB expression.
- To elucidate the connection between miR-10b, MICB, and immune evasion in metastasis.
- To understand the molecular mechanisms underlying cancer metastasis and immune escape.
Main Methods:
- Analysis of miR-10b and MICB expression in metastatic cancer models.
- Investigating the regulatory relationship between miR-10b and MICB.
- Assessing the impact of miR-10b on NK cell activation and anti-tumor immunity.
Main Results:
- miR-10b was found to inhibit the expression of MICB.
- Suppression of MICB by miR-10b leads to reduced NK cell activation.
- This pathway facilitates immune evasion and promotes metastasis formation.
Conclusions:
- miR-10b-mediated inhibition of MICB is a key mechanism for cancer immune evasion.
- Targeting this pathway could offer novel therapeutic strategies against metastasis.
- Understanding miR-10b's role in immune evasion is crucial for improving cancer treatment outcomes.
Related Concept Videos
MicroRNAs
MicroRNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Tumor Microenvironment
